AMCIL Limited (AMH) Earnings Call Transcript & Summary
July 28, 2026
Earnings Call Speaker Segments
Operator
operatorGood morning, and thanks for joining the AMCIL Full Year Financial Results Briefing. Right now everyone is in listen-only mode. After a presentation, we'll move into a question and answer session. Questions will come through the webcast. If you want to raise one when that time comes, just type it into the Ask a Question box located at the bottom of the webcast window. At this point I'll pass things to Alison Gibson, Managing Director of AMCIL. Thank you — over to you.
Alison Gibson
executiveThanks, and good afternoon, everyone. It's a pleasure to have you with us for this briefing on our full year results. My name is Alison Gibson, and I serve as CEO and Managing Director of AMCIL Limited. I've come back to the team quite recently, after five years at HESTA, where I worked as portfolio manager and built up the Australian equities team. The reason I say I've come back is that I was portfolio manager with this company between 2011 and 2021. I'm genuinely thrilled to be here with the team again, and I'm looking forward to meeting shareholders and speaking with them in the months ahead. Before anything else, I want to acknowledge the traditional owners and custodians of all the lands on which we're gathered today, and to pay my respects to their elders — past, present, and emerging. With me on the webinar today are Winston Chong, our portfolio manager for AMCIL; Brett McNeill and Kieran Kennedy, portfolio managers in the team; Andrew Porter, our CFO; Matthew Rowe, our secretary; Geoff Driver, GM Business Development and Investor Relations; Claire Aitchison, Head of Business Development and Investor Relations; and Suzanne Harding, Business Development Manager. This briefing draws on material that's available on the company's website. The presentation slides will advance automatically through the webcast. Let me move now to the first slide, the disclaimer, which makes the point that our purpose here is to discuss the company, not to give any individual investment advice.
Alison Gibson
executiveNow on slide three, that lays out the lineup of speakers for this afternoon. I'll go through the main features of AMCIL, and after that hand things over to Andrew for the results. Winston will take you through markets, the portfolio, and finally the outlook. Once the formal presentation wraps up, we'll come back to questions and answers. Through the webcast, you can submit a question using the tab located at the bottom of your screen. Over to slide five now, the key features of AMCIL. Our aim is to deliver attractive returns for shareholders by combining capital growth over the medium to long term with fully franked dividends. AMCIL runs a high-conviction portfolio made up of 30 to 40 stocks, spanning both large and small companies, with quality as the focus — meaning businesses that hold a sustainable competitive advantage, earn attractive returns on capital, keep solid balance sheets, and have quality management. Our team's interests are aligned with those of shareholders, with a comparatively low management cost and no performance fees. Directors and staff hold equity ownership alongside shareholders. Because we take a long-term approach, turnover comes out lower, which is more tax effective for shareholders. On to slide six. This chart lays out AMCIL's dividend history, including special dividends, across the last five years. With AMCIL's portfolio actively managed, the company is able to generate a significant amount of realized capital gains and franking credits from one year to the next.
Alison Gibson
executiveThose can be applied to add to underlying earnings in order to support dividend payments. Beyond that, realized gains are available for paying special dividends, and that represents a meaningful advantage for shareholders. Slide seven is the last one I will address. It relates to AMCIL's objective. I will pause briefly while the slides catch up. It concerns AMCIL's goal of achieving capital growth together with franked dividends across the medium to long term. Such figures incorporate the franking benefit. Across 25 years, the portfolio's performance has exceeded the index. Even so, results have fallen behind of late, and Winston will cover that afterward in the presentation. Moving to slide eight, I will now pass things to our CFO, Andrew Porter, who will go through the financial results. Thank you, Andrew.
Andrew Porter
executiveThanks, Alison, and good afternoon everyone. On the slide currently displayed you'll find the summary of results for the year, in a layout that I'm sure many of you will recognise. Profit for the year, as you can see, came in marginally higher. Dividends received fell, largely because of smaller holdings in Wesfarmers and the banks, while the interest we received rose. The options written portfolio contributed more, and expenses came in roughly 10%, or AUD 200,000, below the prior year. Expenses are typically talked about by reference to the MER, or management expense ratio, which appears in the box at the bottom left. For the year it was 0.57%, or AUD 0.57 per AUD 100 invested. The calculation takes the expense divided by the average portfolio for the year. Even though expenses declined during the year, the MER edged slightly higher owing to the drop in portfolio value, which we'll cover in more detail later. Notwithstanding that modest rise, the MER is consistent with, or even under, years in which the MER was far higher. The portfolio in the bottom right corner, which we've discussed, went from AUD 411 million last year to AUD 339 million this year, and Winston will shortly walk through some of the main drivers behind that.
Andrew Porter
executiveOn dividends, Alison brought up a realized gain. Realized gains came to AUD 6.1 million this year, versus AUD 13.7 million a year earlier. That cut the special dividend we could pay, from AUD 0.03 last year to AUD 0.005 this year. Though lower than 2025, the total dividend matched 2024. We'll keep setting dividends with reference to earnings and realized gains, plus the availability of franking credits. On that point, I should note we hold in reserve franking credits enough for about AUD 0.04 of dividend once the final and special are paid this year. This next slide shows the premium discount of the NTA to the share price. While basically flat versus the same time a year ago, the board watches it closely, and we publish it each month alongside the NTA. In fact, we flag it weekly through the estimated NTA we release Monday morning, which we set against the share price. Investors ought to be well aware of it too, since on these numbers they can buy AUD 100 worth of investments for AUD 84. We've stepped up marketing across all four LICs, and Claire and Suzanne are proof of that, including drawing attention to the benefits of an LIC structure.
Andrew Porter
executiveWe've also repurchased some shares whenever it looked like the right move. During the previous financial year, roughly AUD 7.6 million in stock was bought back. Still, the single most valuable step we can take, perhaps, is lifting how the portfolio performs. AMCIL tends to swing more than the other LICs, and sadly, this year those swings have gone against us. With that, plus further detail on what has taken place and a look toward what lies ahead, I'll pass things to Winston.
Winston Chong
executiveThanks, Andrew, and good afternoon, everyone. For anyone here I haven't yet had the chance to meet, I've spent two years with the group as assistant portfolio manager of AFIC, and I'm very pleased to now serve shareholders in this new capacity after my recent appointment as portfolio manager of AMCIL. I see it as a real privilege, and I'm stepping into the position with a deep sense of responsibility and stewardship of shareholder capital, along with delivering long-term value for shareholders over the years to come. My experience in markets as both an analyst and an investor spans more than 15 years. Since I'm an AMCIL shareholder myself, I'm excited by the chance to collaborate with our team to lift investment performance. I'm eager to meet our fellow shareholders over the weeks and months ahead. If we turn to slide 12 on performance: this has been a disappointing year for AMCIL shareholders. The portfolio delivered a return of -10%, which represents AMCIL's total return, inclusive of franking and all costs and taxes paid. That trailed the market's return of +7.2%, including franking. These FY 2026 returns have likewise weighed on AMCIL's three, five, and 10-year returns, all of which also sit behind benchmark.
Winston Chong
executiveLike Alison mentioned before, the longer-term returns remain solid, though it's clear that recent results have fallen short of expectations. In the next couple of slides, we'll go through some of what drove this performance over the last year. Moving to slide 13. This slide gives an overview of total returns for the ASX 200 along with the various sectors that comprise the market. Sector returns diverged sharply in financial year 2026. Materials stood out at 52% up, powered by the major miners, BHP and Rio, both of which rose 68% during the year. Gold, lithium, and smaller resource companies were strong as well. At the other end, healthcare and IT were the weakest performers, falling 36% and 37% respectively, with stocks such as CSL, ResMed, Cochlear, WiseTech, and Xero all down materially. AMCIL was positioned unfavorably against these moves, with a large underweight to materials and a significant overweight in both healthcare and IT. As such, sector positioning was a significant headwind to AMCIL's relative performance in financial year 2026. Turning to slide 14, we provide some additional detail on the key stocks that drove the portfolio's relative underperformance. On the left-hand side, the negative contributors or detractors, overweight positions in CSL, ARB, Gentrack, and WiseTech, as well as an underweight position in BHP, all contributed meaningfully to relative underperformance.
Winston Chong
executiveTaken together, those five laggards made up slightly less than 50% of the shortfall. I'll go through them one by one. CSL proved especially weak, hit by several cuts to earnings forecasts caused by competitive strain, lower vaccination uptake, and poor results at Vifor. The firm additionally revealed changes at both the CEO and CFO positions over the period. All of this combined produced a substantial decline in the stock's valuation. ARB likewise suffered from reduced earnings guidance, mirroring a softer home market and pressure on margins, and that in turn caused a steep compression in its valuation multiple. We are keeping our positions in both businesses, since we still see them as high-quality franchises with appealing long-term potential. Over the past six months we have trimmed the portfolio's exposure to each of them, reflecting the murky short-term outlook for both. BHP has gained from a firm iron ore price and a strong copper price. The portfolio's underweight stance there added to relative underperformance during a year in which the share price has climbed 68%. Both Gentrack and WiseTech have been swept up in the wider sell-off in software names driven by artificial intelligence since the beginning of this calendar year. Separately, each has faced its own company-specific troubles, with Gentrack cutting its earnings guidance in May because of a lull in high-margin project work and delays in securing project wins.
Winston Chong
executiveWiseTech likewise experienced a slower year of growth, though concerns about customers moving to a new commercial model, along with lingering governance risks, have caused the market to de-rate the stock heavily. Turning to the positive contributors, you might remember that AMCIL exited its position in CBA during the prior year. CBA's underlying business has stayed sound, but the stock de-rated from an elevated valuation at the start of the year. Because of that, it contributed positively to AMCIL's relative performance. Woolworths, in which the portfolio has held an overweight position, was a strong contributor, as the company recovered from issues in the prior year and showed improved sales trends and a sharper focus on costs. ALS, a provider of testing services to the life sciences and mining industries, contributed positively to portfolio returns thanks to strength in its commodities testing business. Redox, though a smaller position in the portfolio, had a strong year of performance, as the market began pricing it as a beneficiary of stronger oil prices through the flow-on effect to chemical prices. AUB contributed positively to portfolio performance, as the stock re-rated off a low multiple following some M&A in the insurance broking sector. Unfortunately, the portfolio's positive contributors were more than offset by its detractors, and this, combined with the sector positioning discussed on the previous slide, drove AMCIL's relative underperformance for the year.
Winston Chong
executiveNow turning to slide 15, where we cover certain portfolio moves aimed at putting the portfolio in a better position for performance. During the last six months, our activity in the portfolio has aimed to take advantage of market dislocations to purchase quality companies at appealing prices, while also focusing the portfolio on stocks where our conviction is strongest. Regarding additions to existing holdings, we have taken advantage of the broad sell-off tied to AI to build up high-quality software and technology names in the portfolio, among them SEEK, Carsales, Netwealth, Technology One, and Temple & Webster. Although we are watching for possible disruption risk arising from the effects of artificial intelligence, very little impact of note has occurred so far, and we think these risks are being priced into the multiples at which the stocks we hold are trading. We have also lately been adding to Sigma Healthcare amid weakness in its share price. Sigma owns the Chemist Warehouse franchise and is posting exceptionally strong growth in sales and earnings. Volatility surrounding the conflict in the Middle East has provided opportunities for us to add to Auckland Airport at a moment when the market has been concerned about how higher oil prices affect airline capacity. History indicates that events of this kind for airports are usually temporary and can offer good buying opportunities.
Winston Chong
executiveOn the flip side, when crude prices began falling as a peace deal for the war appeared increasingly probable, Woodside's stock pulled back, and we used that dip to build up our holding. What draws us to Woodside is the substantial cash flow expansion expected across the coming few years, and we think that holds even with weaker oil prices once these projects begin producing. Finally, we increased our existing stake in Block, since our conviction that product innovation and market share will fuel robust earnings growth and cash generation keeps getting confirmed. The firm still trades at a very attractive multiple, carries a net cash balance sheet, and is engaged in capital management. We also brought three new names into the portfolio during the past six months. We established initial positions in Ramsay Health Care and ASX. Over a number of years, both businesses have stumbled on execution and strategy. We believe there is room for a turnaround now that new management has been appointed at each company, backed by their distinctive assets and competitive standing. We likewise added insurance broker AUB Group. Its share price has dropped considerably owing to sentiment surrounding artificial intelligence as well as cyclical softness in the premium rate cycle.
Winston Chong
executiveAUB has built an impressive history of expansion, and we expect that once premium rates eventually recover, that expansion will pick back up. To pay for this purchasing, we have reduced positions in several stocks that had done well and were getting close to full valuations, among them Macquarie Technology, Woolworths, Reece, ALS, and Macquarie Group. The cut to BHP came about because of option exercises during the period, whereas the trim to CSL reflected lower conviction after the departure of the former CEO. We also made six full exits during the period as part of an effort to focus the portfolio on a smaller number of high-conviction names. The sales of Redox, PEXA, WiseTech, IDP, and the Environmental Group all stemmed from diminished conviction regarding the quality characteristics of those stocks. As for REA, we continue to view it as a high-quality company. Even so, we exited on relative grounds, with the proceeds helping to fund our purchases in SEEK and Carsales. Turning to slide 16. This gives you a snapshot of the portfolio as at the 30th of June 2026. Total portfolio value stood at AUD 340 million spread across 41 Australian and New Zealand-listed stocks, which came to a net tangible asset value of AUD 1.08 per share.
Winston Chong
executiveWe also present the top 20 positions in the portfolio here. On the slide you can see we hold a blend of stocks primarily for growth, such as Goodman Group, ResMed, and Sigma, plus stocks held for income, including Transurban, Telstra, and Region. The portfolio spans a range of industries: financials such as Macquarie, industrials such as Mainfreight, retailers Woolworths and Wesfarmers, some technology via CAR Group and Block, resources and energy through BHP and Woodside, and real assets like Auckland Airport. In our view, a diversified portfolio of high-quality companies is a key enabler for AMCIL to deliver on its investment objectives through the cycle, and we keep looking for opportunities to refine the portfolio's composition in support of those objectives. Moving now to the outlook on slide 18. Regarding markets, it's interesting to note that FY 2026 was in fact the fourth consecutive year of positive returns for the Australian share market. That is a fairly remarkable result given the shocks that have hit economies and markets in recent times, from events such as the Trump tariffs last year, interest rate volatility, and of course, the ongoing Middle East conflict. On market valuation, as the chart at left shows, the Australian share market currently trades at just over 17x forward earnings.
Winston Chong
executiveThat said, it is under the recent peak of 20x, though still higher than the 15.1x long-term average. Looking at dividend yield, which is another valuation measure, the right-hand side shows the market offering a forecast yield of just 3.7% at present, under the 4.5% long-term average. So in our view, both of these valuation metrics tell us the overall market is moderately expensive at current levels. Moving to slide 19. With that valuation backdrop, we stay focused on making sure the portfolio has strong long-term prospects, grounded in the quality of our companies and where their valuation sits. Even though last year's performance fell short of expectations, when we look through the portfolio companies, we note that many have strong balance sheets and are well placed to deliver continued earnings growth, which in our experience drives share prices over the long term. We keep actively assessing the portfolio and testing our conviction in our holdings, particularly watching for changes in quality and ensuring valuation discipline. In our view, focusing on both of these factors is key to achieving better long-term returns for AMCIL shareholders going forward. As we head into the upcoming reporting season, the portfolio holds a healthy level of cash, and we will monitor carefully for opportunities to take advantage of short-term dislocation in quality companies.
Winston Chong
executiveTo wrap up, I appreciate your interest and the time you've given us, and now I'll turn things over to Geoff so we can take your questions.
Geoff Driver
executiveAll right. Thank you, Winston. Just a quick reminder about asking questions — you do that by going to the bottom of the page and using the Ask a Question box. I've got a couple here that relate to performance, and both are fairly long, so I'll take them one at a time. The answer on performance fell a very long way short of the benchmark index. Mathematically, it seems the sole route by which that gap could be closed in the near term would be a huge drop in the ASX 200 — say 40% — while the quality and conservative AMCIL portfolio declined only 20%. In that case AMCIL would come close to matching how the benchmark index performed. Does either investment team see another route by which performance could narrow the gap to the target index performance? Winston?
Winston Chong
executiveYes. As the chart we presented and the figures we have indicate, we recognize that recent results have been disappointing, and that has affected the 1-, 3-, 5-, and 10-year figures, as we showed earlier. Over the longer term, clearly, the performance Alison presented on that chart, at the beginning, remains positive. I think we are looking at the portfolio here and now and ahead, and at what we can do to affect future returns. For us, that is a risk-and-return equation on both sides. When it comes to the portfolio's volatility, AMCIL will always be a higher-volatility portfolio, and returns will be more volatile than other funds in the AFIC stable. Even so, we are still seeking to manage risk and to maximize return for that risk. From this point forward, we are taking steps, and we can give a more detailed update later this year at the AGM on exactly what we are doing. That is the intention — that we are unhappy and dissatisfied with this year's performance and its effect on the longer-term figures, and are examining measures to turn it around. I would say our focus remains on quality; we are not changing our investment philosophy.
Winston Chong
executiveWe're on the lookout for iterations in which we can make improvements.
Geoff Driver
executiveAppreciate that, Winston. And I suppose this question also touches on, let's say, how ETFs are influencing the market. "I've held shares since AMCIL started. I'm a long-term investor in every one of the LICs in the stable. AMCIL's more active approach satisfied me previously, but the latest financial results demonstrate that its active management style hasn't really delivered. With the huge flows into ETFs — inflows, I should say — and computer-driven styles running a lot of the passive funds, perhaps now is the moment to be somewhat faster and more responsive when share prices move, with many of those moves pushed by these new investment approaches. Even if that means paying more tax, it would generate higher franking credits and could help trim sizable capital losses in the big portfolio holdings. The entire market is being shaped by enormous index-based, computer-driven investing from super funds and ETFs. I believe AFIC's, AMCIL's management style might need refreshing, since it's classified as an actively managed fund."
Alison Gibson
executiveI may come in at this point—
Geoff Driver
executiveYes, thank you, Alison.
Alison Gibson
executiveAll right, Geoff, if that works. Clearly, I'm still very new in the CEO role. We're roughly two weeks in, and I'm spending time with the team going through everything. On performance, Winston was clear that it's disappointing — we feel that disappointment too, and we're putting in a lot of effort to make things better from here. Importantly, as Winston also mentioned, the mandate and the investment philosophy built around a focus on quality companies are not going to change. We will be reviewing processes and areas like risk management and how we're integrating AI, but the fundamentals of investing in quality won't shift. I've spent 25 years in markets and have watched a number of cycles in which sectors and particular stocks can get over-hyped for a period of time, and that can mean we underperform an index over shorter periods. As a team, we do believe quality will perform over the long term. Now, we clearly need to examine and assess what has happened and carry some of the learnings forward, and as a team we are absolutely doing that. It's pleasing to have someone like Winston now focused on the portfolio going forward, and he has already made a number of changes to the way we're looking at it.
Alison Gibson
executiveAs I mentioned, I'm genuinely encouraged by what we're seeing in these first few days, and we'll return to shareholders at this October's AGM to discuss in greater detail some of the changes we're putting in place, and with luck the better performance will show through over the long term.
Geoff Driver
executiveThanks, Alison. I’d like to ask about Redox. What was the rationale behind leaving that position? It seems to be a business with solid fundamentals, a good record over the long term, and substantial alignment between management and shareholders.
Kieran Kennedy
executiveYeah, this is Kieran Kennedy. Clearly, the portfolio manager focuses on smaller companies such as Redox within the group. Regarding the question, I agree with much of what was said there, and that is the reason it was held in the portfolio, is something we keep monitoring, and is a stock we still own in Mirrabooka. I suppose one aspect we consider with a stock like Redox is that its revenue is affected fairly heavily by the prices of the product it sells, which it does not control. When it comes to the chemicals it distributes, it is a price taker. That is what the business does. This produces a certain amount of volatility in the earnings, and obviously, with some of the inflationary things witnessed around the world lately, that has worked in their favor. We have seen in recent years — it was actually a lower point in the cycle. Going back to some of the earlier questions, we are mindful of earnings volatility and the additional share price volatility you can get as a result, particularly in smaller companies. When we are at a point in the cycle that we think is quite full, we think it is prudent to move the position on, but it is one we will continue to keep an eye on if opportunities arise in future cycles.
Geoff Driver
executiveThanks, Kieran. Andrew, I’ve got a question for you: at the end of June, what percentage of the portfolio was held in cash?
Andrew Porter
executiveBy the close of June, cash made up 5% of the overall portfolio.
Geoff Driver
executiveWhen you look at it in the context of AMCIL, that's a sensible cash position to be in.
Winston Chong
executiveYes — we're aware that the dividend is something we're paying out.
Geoff Driver
executiveYou've got it.
Winston Chong
executiveWe're also setting aside some cash that we can put to work on opportunities during this reporting season.
Geoff Driver
executiveThanks, Winston. One more thing about performance. With that big shortfall, I wonder if AMCIL is moving fast enough to respond to the losing positions in the portfolio.
Winston Chong
executiveThat's a really good question. As a team, we've given this some thought, especially given shifts in market structure and the volatility we're seeing in the share market. I think for AMCIL in particular, we consider what its competitive advantages are. One is that we have a fixed capital base. We're able to take a long-term view, and we're also smaller than the other funds, so we can be more nimble and active — I think that opportunity definitely exists. Hopefully, when we provide an update later this year, we can share some examples of how we've been more active around changes in our conviction, whether driven by valuation or quality factors under our process. That's certainly one of the changes we're looking to make — to be slightly more active, and also to act on shifts in conviction.
Geoff Driver
executiveAppreciate that, Winston. Once more, a quick reminder to submit questions through the Ask Question box located at the bottom of the webcast. I noticed — I believe the name shown is Mirrabooka, though I think that's actually AMCIL — that a share buyback has been initiated. Has that buyback delivered the outcome you were after?
Andrew Porter
executiveYou're correct that Mirrabooka has never done a share buyback before; it has now announced that it will have the ability to do so. As for the AMCIL buyback, the main reason we carried out that buyback was that the discount at that time was such that we saw it as good fundamental value to purchase that portfolio of companies at that discount. We'll keep that under review and continue looking at it.
Geoff Driver
executiveWe’ll now move to the consideration section.
Andrew Porter
executiveIt's something we're looking at. Keep an eye out — that isn't to say it won't happen, but if the right opportunity comes along, we'll make the most of it.
Geoff Driver
executiveThanks, Andrew. One question for you, Winston: does the portfolio team stay in close touch with the management companies you invest in as well as the businesses tied to them?
Winston Chong
executiveAbsolutely. That's a central element of how we work. On the quality side, when we're scoring companies, people matter a great deal — we believe we need to hold stakes in businesses run by individuals we have confidence in so that value can be created over the long term. We stay in regular touch with the management teams, meeting with them no fewer than two times annually, and often more. Alongside that — and this is something the question also hints at — we conduct industry channel checks as a supplement. So to wrap up: yes, people form a highly significant piece of our process.
Geoff Driver
executiveThanks, Winston. Smaller companies are naturally more volatile. From what you said about Redox, it sounds like management is aiming to put more money in. Does it seem that management is also looking to invest more at the large end of the spectrum?
Winston Chong
executiveAMCIL has a wide-ranging mandate that lets it invest right across the spectrum, in both large and small companies. I wouldn't characterize it as a preference for putting money into the large end of the spectrum. What I would say, however, is that in the small cap space there's typically more volatility and more risk, whether that comes as liquidity risk or business risk. What we try to do in managing that risk is to size positions appropriately when we invest in small caps, in line with the reward we're hoping they deliver for us too. For us, it's really a matter of position sizing rather than having a preference for one or the other.
Geoff Driver
executiveAppreciate it, Winston. This is more of a remark, though I suspect a question is buried in it. A lot of the stocks we held in the portfolio generated no profits at all, or only tiny ones, paired with P/E ratios that were extraordinarily lofty. I just can't accept calling businesses with no earnings "quality." That's part of why performance has been so weak. Let's stay with genuine quality — meaning the stocks actually produce earnings, which I believe you mentioned earlier, Winston.
Winston Chong
executiveHonestly, I would refer this question back to the slides we went through that explain the underperformance. Most of those companies do have earnings — I'd push back on that question. We view earnings this way: one of the remarks I made earlier is that earnings are a significant driver of share prices, and as a team that's something we believe. When assessing quality, one factor we examine is earnings growth, and earnings persistence is the other quality.
Geoff Driver
executiveOnce more, as a reminder, everyone can submit a question at the bottom of the webcast using the question box.
Alison Gibson
executiveIf I had the chance, I might return to this point later.
Geoff Driver
executiveAbsolutely, happy to.
Alison Gibson
executiveI believe I didn't completely address the earlier question regarding the market structure and volatility we're currently witnessing, along with the move toward passive investing—especially in the super fund space, having worked in that environment myself. These days, taking a long-term view is difficult for many investors, and I see that as one of the competitive advantages AMCIL holds and will keep leveraging as we move forward. We're witnessing enormous volatility, and honestly, in my entire career, I've never encountered anything quite like it. I genuinely believe there's a significant opportunity for investors capable of genuinely adopting a long-term perspective to move into that volatility and purchase quality at what are truly attractive prices we're observing in the market. Now, we accept the fact that Winston has done an excellent job, I think, discussing some of the difficulties we encountered over the last 12 months. We acknowledge that this performance has been unacceptable for shareholders, and we will be redoubling our efforts to review how we examine markets and stocks, with that emphasis on quality and ensuring we invest in that area for the long term.
Alison Gibson
executiveAs I mentioned, we're hoping to share additional details at the October AGM. In the present climate, I genuinely believe long-term investors have an appealing opportunity here.
Geoff Driver
executiveThanks, Alison. Here's a question: would AMCIL consider putting a small percentage toward international shares inside the portfolio?
Andrew Porter
executiveHistorically, that isn't a route we've taken. I'd say you should never say never, yet right now it would certainly need to be the right opportunity, and with the exchange rate as it stands, buying U.S. dollar-denominated stocks isn't favorable for us. We would never rule it out, though it isn't something sitting immediately on the radar.
Geoff Driver
executiveOf course the AFIC team has certain capabilities in place. That would factor into the thinking—
Andrew Porter
executiveSure.
Geoff Driver
executiveShould AMCIL ever choose to take that path. Alison, I have nothing further to ask, so I believe we can wrap up the meeting now.
Alison Gibson
executiveYes. Thank you so much, everyone, for joining us, and we’re eager to talk with all of you and give an update during the AGM in October. We’ll see you at that point. Thanks.
Operator
operatorThanks. That brings today’s webinar to a close. We appreciate everyone taking part. You can go ahead and disconnect your lines now.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete AMCIL Limited transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.
Get the API View API docs →This call discussed
For developers and AI pipelines
Programmatic access to AMCIL Limited earnings transcripts and 132,000+ others is available through the
EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments,
full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.
More tools for stock research
OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in AMCIL Limited or any ticker on your watchlist.
StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.